Newsroom

Sorted by: Latest

-

Carmila: Information Concerning the Total Number of Voting Rights and Share

PARIS--(BUSINESS WIRE)--Regulatory News: Carmila (Paris:CARM): Date Total number of issued shares Number of real voting rights (excluding treasury shares) Theoretical number of voting rights (including treasury shares)* 31 May 2026 139,616,607 138,604,990 139,616,607 *Pursuant to article 223-11 of the Règlement Général de l’Autorité des marchés financiers. CARMILA French société anonyme with a share capital of €837,699,642 Registered office: 25, rue d’Astorg, 75008 Paris - France Registered at...
-

Carmila : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiers 

PARIS--(BUSINESS WIRE)--Regulatory News: Carmila (Paris:CARM): Date Nombre d’actions composant le capital social Nombre réel de droits de vote (déduction faite des actions auto-détenues) Nombre théorique de droits de vote (y compris les actions auto-détenues)* 31 mai 2026 139 616 607 138 604 990 139 616 607 *en application de l’article 223-11 du Règlement général de l’Autorité des marchés financiers. CARMILA Société anonyme au capital de 837 699 642 euros Siège social : 25, rue d’Astorg, 75008...
-

NFL Biosciences publie de nouveaux résultats sur NFL-101 et confirme son approche personnalisée du sevrage tabagique

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des médicaments botaniques innovants pour le traitement des addictions, présente aujourd'hui les résultats des analyses d'efficacité réalisées dans une population cible définie par un biomarqueur prédictif associé à NFL-101, candidat-médicament dans le sevrage tabagique. Bruno Lafont, Directeur Général et co-fondateur de NFL Biosciences, dé...
-

NFL Biosciences Releases New Results on NFL-101 and Reaffirms Its Personalized Approach to Smoking Cessation

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing innovative botanical drugs for the treatment of addictions, today presents the results of efficacy analyses conducted in a target population defined by a predictive biomarker associated with NFL-101, a drug candidate for smoking cessation. Bruno Lafont, Chief Executive Officer and co-founder of NFL Biosciences, states: “These results repre...
-

Eurofins Scientific SE: Weekly Report on Share Repurchases From 25th May to 29th May 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 25/05/2026 FR0014000MR3 25 000 62.9108 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 25/05/2026 FR0014000MR3 5 000 63.1452 CEUX EUROFINS SCIENTIFIC 529900JEHFM4...
-

AltynGold Plc UK Regulatory Announcement: AGM Statement

LONDON--(BUSINESS WIRE)--  AltynGold Plc ("AltynGold" or the "Company") Growth Strategy Update and Annual General Meeting London, 1 June 2026 - AltynGold (LSE:ALTN), a leading exploration and development gold miner operating in Kazakhstan, is pleased to provide the following update regarding the ongoing development of its assets. Following a transformational period for the Company, during which it successfully expanded its Sekisovskoye processing capacity to 1 Mtpa on time and on budget, enabli...
-

Assured Guaranty (Europe) Ltd UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: Assured Guaranty (Europe) Ltd GBP 47,000,000.00 MATURING: 28-Jan-2041 ISIN: XS2343845629 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 28-Nov-2025 TO 28-May-2026 HAS BEEN FIXED AT .00 PCT DAY BASIS: ACTUAL/365(PROP) INTEREST PAYABLE VALUE 28-May-2026 WILL AMOUNT TO: GBP 454,264.70 PER GBP 47,000,000.00 DENOMINATION  ...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: First Abu Dhabi Bank P.J.S.C. USD 46,000,000.00 MATURING: 07-Sep-2028 ISIN: XS2677752573 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 09-Mar-2026 TO 08-Jun-2026 HAS BEEN FIXED AT 4.59 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 08-Jun-2026 WILL AMOUNT TO: USD 2,321.35 PER USD 200,000.00 DENOMINATION  ...
-

IDE Technologies Secures Bid for Largest Seawater Desalination Facility in Western Hemisphere

KADIMA, Israel--(BUSINESS WIRE)--IDE Technologies, a leading global provider of desalination and water treatment solutions, today announced it was unanimously selected by the Nueces River Authority Board to develop the Harbor Island Desalination Facility. The project, which is designed to deliver 100 million gallons of water per day to South Texas, will be the largest seawater desalination facility in the Western Hemisphere. With drought outlooks underscoring the need for more resilient water p...
-

Citibank UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  Re: The Toronto-Dominion Bank (Covered Bonds) EUR 1,000,000,000.00 MATURING: 03-Sep-2027 ISIN: XS2895483787 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 03-Jun-2026 TO 03-Sep-2026 HAS BEEN FIXED AT 2.56 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 03-Sep-2026 WILL AMOUNT TO: EUR 6,529,444.44 PER EUR 1,000,000,000.00 DENOMINATION  ...